Publicaciones en las que colabora con José Manuel Aramendía Beitia (17)

2022

  1. A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

    Cancers, Vol. 14, Núm. 12

2021

  1. Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis

    Clinical and Translational Oncology, Vol. 23, Núm. 9, pp. 1934-1941

  2. The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes

    British Journal of Cancer, Vol. 124, Núm. 6, pp. 1138-1149

2018

  1. Erratum: Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial (Brachytherapy (2018) 17(5) (734–741), (S1538472118300898) (10.1016/j.brachy.2018.04.007))

    Brachytherapy

  2. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial

    Brachytherapy, Vol. 17, Núm. 5, pp. 734-741

2016

  1. Long-Term Results of a Phase II Trial of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer

    International Journal of Gynecological Cancer, Vol. 26, Núm. 6, pp. 1162-1168

  2. Multicatheter breast implant during breast conservative surgery: Novel approach to deliver accelerated partial breast irradiation

    Brachytherapy, Vol. 15, Núm. 4, pp. 485-494

2010

  1. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer

    International Journal of Gynecological Cancer, Vol. 20, Núm. 1, pp. 133-140

  2. Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer

    Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465

2008

  1. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy

    Brachytherapy, Vol. 7, Núm. 4, pp. 310-315

2004

  1. A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patients

    Bone Marrow Transplantation, Vol. 33, Núm. 5, pp. 499-502

2002

  1. Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer: A feasibility pilot study

    Oncology, Vol. 63, Núm. 3, pp. 254-265

  2. Radiation therapy after high-dose chemotherapy with peripheral blood stem cell support for high-risk breast cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, Núm. 4, pp. 347-353

1997

  1. Cisplatin, mitomycin, and vindesine followed by intraoperative and postoperative radiotherapy for stage III non-small cell lung cancer: Final results of a Phase II study

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 20, Núm. 3, pp. 276-281

  2. Intensive chemotherapy in the treatment of patients with metastatic breast cancer

    Revista de medicina de la Universidad de Navarra, Vol. 41, Núm. 3, pp. 143-151

1994

  1. Combined treatment in superior sulcus tumors

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 17, Núm. 4, pp. 317-322

1993

  1. Advanced germinal tumors of the testicle: clinical experience with cisplatin, bleomycin and vinblastine (PVB) or etoposide (BEP)

    Revista de medicina de la Universidad de Navarra, Vol. 38, Núm. 1, pp. 13-18